Abstract
Fibromyalgia (FM) is a common chronic pain disorder that presents diagnostic challenges for clinicians. Several classification, diagnostic and screening criteria have been developed over the years, but there continues to be a need to develop criteria that reflect the current understanding of FM and are practical for use by clinicians and researchers. The Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks, (ACTTION) public-private partnership with the United States (U.S.) Food and Drug Administration (FDA) and the American Pain Society (APS), initiated the ACTTION-APS Pain Taxonomy (AAPT) to develop a diagnostic system that would be clinically useful and consistent across chronic pain disorders. The AAPT established an international FM working group consisting of clinicians and researchers with expertise in FM to generate core diagnostic criteria for FM and apply the multidimensional diagnostic framework adopted by AAPT to FM. The process for developing the AAPT criteria and dimensions included literature reviews and synthesis, consensus discussions, and analyses of data from large population-based studies conducted in the United Kingdom (U.K.). The FM working group established a revised diagnosis of FM, and identified risk factors, course, prognosis, and pathophysiology of FM. Future studies will assess the criteria for feasibility, reliability and validity. Revisions of the dimensions will also be required as research advances our understanding of FM. PERSPECTIVE: The ACTTION-APS FM taxonomy provides an evidence-based diagnostic system for FM. The taxonomy includes diagnostic criteria, common features, comorbidities, consequences, and putative mechanisms. This approach might improve the recognition of FM in clinical practice.
| Original language | English |
|---|---|
| Pages (from-to) | 611-628 |
| Number of pages | 18 |
| Journal | Journal of Pain |
| Volume | 20 |
| Issue number | 6 |
| Early online date | 16 Nov 2018 |
| DOIs | |
| Publication status | Published - Jun 2019 |
Fingerprint
Keywords
- Fibromyalgia
- diagnosis
- criteria
- AAPT
- dimensions
- INTRINSIC BRAIN CONNECTIVITY
- CHRONIC WIDESPREAD PAIN
- OF-RHEUMATOLOGY 1990
- MUSCULOSKELETAL PAIN
- CENTRAL SENSITIZATION
- HYPOTHALAMIC-PITUITARY
- SYNDROME/EHLERS-DANLOS SYNDROME
- HEALTH-CARE COSTS
- CHRONIC-FATIGUE-SYNDROME
- IRRITABLE-BOWEL-SYNDROME
ASJC Scopus subject areas
- Clinical Neurology
- Neurology
- Anesthesiology and Pain Medicine
Cite this
AAPT Diagnostic Criteria for Fibromyalgia. / Arnold, Lesley M (Corresponding Author); Bennett, Robert M; Crofford, Leslie J; Dean, Linda E; Clauw, Daniel J; Goldenberg, Don L; Fitzcharles, Mary-Ann; Paiva, Eduardo S; Staud, Roland; Sarzi-Puttini, Piercarlo; Buskila, Dan; Macfarlane, Gary J.
In: Journal of Pain, Vol. 20, No. 6, 06.2019, p. 611-628.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - AAPT Diagnostic Criteria for Fibromyalgia
AU - Arnold, Lesley M
AU - Bennett, Robert M
AU - Crofford, Leslie J
AU - Dean, Linda E
AU - Clauw, Daniel J
AU - Goldenberg, Don L
AU - Fitzcharles, Mary-Ann
AU - Paiva, Eduardo S
AU - Staud, Roland
AU - Sarzi-Puttini, Piercarlo
AU - Buskila, Dan
AU - Macfarlane, Gary J
N1 - Acknowledgements Support was provided by the Analgesic, Anesthetic, and Addictions Clinical Trial Translations, Innovations, Opportunities, and Networks public-private partnership with the US Food and Drug Administration (FDA).
PY - 2019/6
Y1 - 2019/6
N2 - Fibromyalgia (FM) is a common chronic pain disorder that presents diagnostic challenges for clinicians. Several classification, diagnostic and screening criteria have been developed over the years, but there continues to be a need to develop criteria that reflect the current understanding of FM and are practical for use by clinicians and researchers. The Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks, (ACTTION) public-private partnership with the United States (U.S.) Food and Drug Administration (FDA) and the American Pain Society (APS), initiated the ACTTION-APS Pain Taxonomy (AAPT) to develop a diagnostic system that would be clinically useful and consistent across chronic pain disorders. The AAPT established an international FM working group consisting of clinicians and researchers with expertise in FM to generate core diagnostic criteria for FM and apply the multidimensional diagnostic framework adopted by AAPT to FM. The process for developing the AAPT criteria and dimensions included literature reviews and synthesis, consensus discussions, and analyses of data from large population-based studies conducted in the United Kingdom (U.K.). The FM working group established a revised diagnosis of FM, and identified risk factors, course, prognosis, and pathophysiology of FM. Future studies will assess the criteria for feasibility, reliability and validity. Revisions of the dimensions will also be required as research advances our understanding of FM. PERSPECTIVE: The ACTTION-APS FM taxonomy provides an evidence-based diagnostic system for FM. The taxonomy includes diagnostic criteria, common features, comorbidities, consequences, and putative mechanisms. This approach might improve the recognition of FM in clinical practice.
AB - Fibromyalgia (FM) is a common chronic pain disorder that presents diagnostic challenges for clinicians. Several classification, diagnostic and screening criteria have been developed over the years, but there continues to be a need to develop criteria that reflect the current understanding of FM and are practical for use by clinicians and researchers. The Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks, (ACTTION) public-private partnership with the United States (U.S.) Food and Drug Administration (FDA) and the American Pain Society (APS), initiated the ACTTION-APS Pain Taxonomy (AAPT) to develop a diagnostic system that would be clinically useful and consistent across chronic pain disorders. The AAPT established an international FM working group consisting of clinicians and researchers with expertise in FM to generate core diagnostic criteria for FM and apply the multidimensional diagnostic framework adopted by AAPT to FM. The process for developing the AAPT criteria and dimensions included literature reviews and synthesis, consensus discussions, and analyses of data from large population-based studies conducted in the United Kingdom (U.K.). The FM working group established a revised diagnosis of FM, and identified risk factors, course, prognosis, and pathophysiology of FM. Future studies will assess the criteria for feasibility, reliability and validity. Revisions of the dimensions will also be required as research advances our understanding of FM. PERSPECTIVE: The ACTTION-APS FM taxonomy provides an evidence-based diagnostic system for FM. The taxonomy includes diagnostic criteria, common features, comorbidities, consequences, and putative mechanisms. This approach might improve the recognition of FM in clinical practice.
KW - Fibromyalgia
KW - diagnosis
KW - criteria
KW - AAPT
KW - dimensions
KW - INTRINSIC BRAIN CONNECTIVITY
KW - CHRONIC WIDESPREAD PAIN
KW - OF-RHEUMATOLOGY 1990
KW - MUSCULOSKELETAL PAIN
KW - CENTRAL SENSITIZATION
KW - HYPOTHALAMIC-PITUITARY
KW - SYNDROME/EHLERS-DANLOS SYNDROME
KW - HEALTH-CARE COSTS
KW - CHRONIC-FATIGUE-SYNDROME
KW - IRRITABLE-BOWEL-SYNDROME
UR - http://www.scopus.com/inward/record.url?scp=85058705131&partnerID=8YFLogxK
UR - http://www.mendeley.com/research/aapt-diagnostic-criteria-fibromyalgia
U2 - 10.1016/j.jpain.2018.10.008
DO - 10.1016/j.jpain.2018.10.008
M3 - Review article
VL - 20
SP - 611
EP - 628
JO - Journal of Pain
JF - Journal of Pain
SN - 1526-5900
IS - 6
ER -